Irritation and Sensitization Study of HP-5000 Topical System
NCT04882319
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis of the Knee
Interventions
DRUG:
HP-5000 Topical Patch
DRUG:
HP-5000 Placebo Patch
DRUG:
Saline Patch
Sponsor
Noven Pharmaceuticals, Inc.